David Malka
Known title: Vice President of OperationsCIK: 0001556758
Associated companies
Transaction History
| GCTK | ▼ Sell | Other | 61,471 | $0 | 3/11/2015 | View on chart |
| GCTK | ▼ Sell | Other | 61,471 | $0 | 3/11/2015 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
GCTK’s Lōkahi Expands Collaboration & Launches Qare
Glucotrack’s subsidiary Lōkahi Therapeutics has broadened its partnership with the University of Georgia and a German university, marking its first international ai² pipeline project. The company also introduced Qare, a real‑time comparative health platform for GLP‑1 medications, which will be publicly available from October 14. These moves expand Lōkahi’s product reach and could enhance Glucotrack’s overall value proposition.
GCTK’s Lōkahi Expands Collaboration & Launches Qare. Glucotrack’s subsidiary Lōkahi Therapeutics has broadened its partnership with the University of Georgia and a German university, marking its first international ai² pipeline project. The company also introduced Qare, a real‑time comparative health platform for GLP‑1 medications, which will be publicly available from October 14. These moves expand Lōkahi’s product reach and could enhance Glucotrack’s overall value proposition.